Effects of captopril and enalapril on zinc metabolism in hypertensive patients

Ahuva Golik, Ronit Zaidenstein, Victor Dishi, Alexander Blatt, Natan Cohen, Gad Cotter, Silvia Berman, Joshua Weissgarten

Research output: Contribution to journalArticlepeer-review

56 Scopus citations


Objective: To investigate the effects of chronic captopril and enalapril treatment on zinc metabolism in hypertensive patients by assessing zinc levels in serum, urine and monocytes. Methods: Patients with newly diagnosed essential hypertension were randomly divided into two treatment groups: those treated with captopril only (n=16) and those treated with enalapril only (n=18). Ten healthy subjects served as controls. Prior to the start of treatment and again 6 months later, zinc was assessed in the serum, in urine collected over 24 hours, and in peripheral blood monocytes. Results: Significant enhancement of 24-hour urinary zinc excretion (μg/24 hour) after 6 months of treatment was observed only in the captopril-treated group (p<0.01). However, intramonocytic zinc levels decreased significantly in both of the treated groups over the same period (p<0.01 and p<0.04 in the captopril- and enalapril-treated groups, respectively). Conclusion: Treatment of hypertensive patients with captopril or enalapril may result in zinc deficiency.

Original languageEnglish
Pages (from-to)75-78
Number of pages4
JournalJournal of the American College of Nutrition
Issue number1
StatePublished - 1 Feb 1998
Externally publishedYes


  • ACE inhibitors
  • Hypertension
  • Zinc metabolism


Dive into the research topics of 'Effects of captopril and enalapril on zinc metabolism in hypertensive patients'. Together they form a unique fingerprint.

Cite this